Global Tuberculin Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Tuberculin Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Tuberculin, also known as purified protein derivative is a combination of proteins that are used in the diagnosis of tuberculosis. This use is referred to as the tuberculin skin test and is recommended only for those at high risk. Injection is done into the skin. After 48 to 72 hours if there is more than a five to ten millimeter area of swelling the test is considered positive.

Market Overview:

The latest research study on the global Tuberculin market finds that the global Tuberculin market reached a value of USD 546.64 million in 2022. It’s expected that the market will achieve USD 787.34 million by 2028, exhibiting a CAGR of 6.27% during the forecast period.

Down Stream Market Analysis

Tuberculosis is a chronic infectious disease caused by tuberculosis bacillus infection. Tuberculosis bacteria may invade various organs of the body, but mainly invade the lungs, known as tuberculosis. Tuberculosis is a chronic and slow-onset infectious disease that is easy to occur in young people. The incubation period was 4 to 8 weeks. 80% of them occur in the lungs, and other parts (neck lymph, meninges, peritoneum, intestine, skin, bone) can also be secondary to infection. Respiratory transmission between people is the main mode of transmission of the disease. The source of infection is tuberculosis patients who are exposed to bacteria. With the spread of environmental pollution and AIDS, the incidence of tuberculosis has become more and more intense. Except for a few cases of acute onset, the clinical manifestations are mostly chronic. It often has systemic symptoms such as low fever and fatigue and respiratory manifestations such as cough and hemoptysis.

Down Stream Demand Analysis

Tuberculosis is still an important cause of disease and death in developing countries. Tuberculosis is the leading killer of adult infections worldwide, second only to HIV. In addition to its health impact, the disease has had a huge impact on the economy, making tuberculosis the main cause of poverty.

Tuberculin, also known as purified protein derivatives, is a combination of proteins used in tuberculosis diagnosis. This use is called tuberculin skin test and is recommended only for high-risk groups. After the injection, it enters the skin. After 48 to 72 hours, if the swelling area exceeds 5 to 10 mm, the test is considered positive. Skin tests for tuberculin (also known as the Mantoux tuberculin test) were conducted to see if people had ever been exposed to tuberculosis (TB).

Key Companies in the global Tuberculin market covered in Chapter 3:

SSI
Par Sterile
Zoetis
Thermo Fisher (Prionics)
Sanofi Pasteur
Japan BCG Laboratory

In Chapter 4 and Chapter 14.2, on the basis of types, the Tuberculin market from 2018 to 2029 is primarily split into:

PPD-S
PPD-RT23
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Tuberculin market from 2018 to 2029 covers:

Human Use
Animal Use

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)